Integrated Insights & DAP Associate
No salary listed
Mid
Bachelor's, Master's
Kazakhstan
In Person
Data & AnalyticsData Management, Business Intelligence
About the job
Requirements
- A university degree in bioscience or business administration.
- Hands-on experience managing, designing, and editing customer relationship management platforms and data platforms such as Salesforce, Veeva, or OnCore.
- Hands-on understanding of statistical methods, machine learning pipelines, feature stores, model monitoring, bias and fairness assessments, and responsible artificial intelligence practices.
- Experience translating complex data initiatives into business value and risk reduction, and presenting data insights to executive audiences.
- Experience working within international data strategy and governance frameworks and ensuring compliance with consent, privacy, and promotional standards.
- Experience leading artificial intelligence use cases for customer engagement and internal productivity from pilot to scale, defining local requirements, and co-owning roadmaps with international CLS DAP in collaboration with international Medical Affairs and Value & Access.
- Experience measuring productivity, engagement, and quality uplift, and ensuring responsible artificial intelligence practices, risk controls, and user enablement.
- Experience partnering with Integrated Insights to design key performance indicator frameworks and automate reporting cadences, and driving adoption across business units, Medical Affairs, Value & Access, Field, and leadership.
- Strong knowledge of applicable industry compliance requirements and standards, including data management, data privacy, promotional practices, field activities, and local laws.
- Experience managing the end-to-end vendor lifecycle, including selection, contracting, service-level agreement definition, delivery oversight, and benefits realization.
Responsibilities
- Translate Therapeutic Area and Value & Access business priorities into clearly defined insight questions, research briefs, and analytical requirements.
- Enable integrated insight generation using internal and external data sources, including market research, competitive intelligence, and performance analytics.
- Prepare insight summaries, deep-dive analyses, and learnings to support planning, review, and resource discussions.
- Promote reuse of international research and knowledge assets before commissioning new local research.
- Prepare market assumptions, analytical inputs, and data sets to support forecasting and scenario discussions led by Finance, Therapeutic Areas, and Value & Access.
- Coordinate inputs across functions to enable a consistent and aligned view of market assumptions and outputs.
- Serve as the operational interface between Therapeutic Areas, Value & Access, Finance, and Data, Analytics and Platforms for forecasting-related analytics and data needs.
- Maintain and feed a federated, trusted view of business-critical data across internal and external data sources.
- Define business rules for data processing and ensure data quality.
- Define and maintain data sources, processing, and quality for Therapeutic Area, Medical, and Access global key performance indicator reporting.
- Ensure alignment with international data governance frameworks.
- Manage processes with third-party data vendors.
- Enable standardized dashboards and reports that highlight business-critical metrics and align with international requirements, including ICE reporting and the IMEx metrics dashboard.
- Enable Access key performance indicators, Medical sub-national metrics dashboards, BEST, Commercial key performance indicators, and ongoing cross-functional analytics and reporting.
- Ensure database management for Medical in accordance with legal and compliance requirements for data access.
- Enable IMA iSEC dashboard and analytics reporting using VIP inputs, including data pulling, data visualization, and data trends, for IMA use and interpretation.
- Ensure reliable data maintenance and reporting, explore automation opportunities, and support Value & Access tendering and Access Account Management business cases.
- Collaborate with regional and cluster Data teams to exchange best practices.
- Drive change management and adoption of international technology platforms, including SFMC, OnCore, C360, OnePSP, and other marketing platforms that enable users to consume information and engage with customers; develop the country implementation roadmap.
- Set the country-level vision, objectives, measures of success, and roadmap.
- Ensure alignment among stakeholders, including field force, Therapeutic Areas, EE, Medical, Value & Access, and customers.
- Enable and implement ICE/IMEx technology readiness, including MEEP and VIP.
- Oversee tagging of IMEx medical content and its upload into FUSE and CRM based on Medical team guidance.
- Maintain CRM and the C360 platform for promotional, Medical Affairs, and Value & Access requirements.
- Enable patient services and solutions experience technology and key performance indicator tracking.
- Manage artificial intelligence and digital products for customer engagement, Medical and Value & Access stakeholder engagement, and internal productivity, and foster their scalability across the enterprise.
- Ensure artificial intelligence uptake and coordinate training with the local capability-building team.
Desired Qualifications
- Experience in pharmaceutical or biotechnology commercial data, digital platforms, or analytics roles.
- An advanced degree in a quantitative or technical field, such as Computer Science, Data Science, Engineering, Bioinformatics, or Biostatistics, or equivalent experience.
- Knowledge of Alteryx.
- Analytical thinking.
- Brand awareness.
- Business networking.
- Digital marketing.
- Marketing communications.
- Marketing planning.
- Marketing strategies.
- Media campaigns.
- Process documentation.
- Statistical analysis.
About the company
Novartis is a global pharmaceutical company that uses science-based innovations to develop treatments and improve patient outcomes worldwide. Its products are medicines developed through research and development to address various diseases, aiming to reach nearly 1 billion people. The company differentiates itself by large-scale investment in R&D, a global presence with a diverse workforce, and a clear mission to Reimagine Medicine, focusing on meeting the changing needs of patients. Its goal is to improve quality of life and extend life expectancy by delivering meaningful therapies through its research and development efforts.
Company Size
10,001+
Company Stage
IPO
Headquarters
Basel, Switzerland
Founded
1970
Get referred to Novartis
See people who can refer or advise you
Simplify's Take
What believers are saying
- Ianalumab won FDA Breakthrough Therapy designation on January 16, 2026.
- Remibrutinib posted positive Phase III data in April 2026 and September 2026.
- The October 2, 2026 Abogen deal adds optionality across autoimmune RNA programs.
What critics are saying
- Entresto generic erosion hits in November 2026 after a September 2026 patent-loss setback.
- Reuters reported two late-stage failures in September 2026 erased nearly $30 billion.
- Novartis faces India pricing pressure over ribociclib; Kerala High Court scrutiny continues.
What makes Novartis unique
- Novartis pairs blockbuster execution with 2026 launches like Rhapsido and Itvisma.
- Its 2026 autoimmune push spans remibrutinib, ianalumab, and Abogen's ABO2203.
- CAS collaboration in September 2026 strengthens Novartis's AI-ready reaction data advantage.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- 401(k) Retirement Plan
- 401(k) Company Match
- Paid Vacation
- Paid Sick Leave
- Paid Holidays
- Hybrid Work Options